Medication for the treatment of cold, cough, and sore throat derived from natural substances fall under the purview of natural cold, cough, and sore throat remedies.Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Natural Cold, Cough, and Sore Throat Remedies estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for Natural Cold, Cough, and Sore Throat Remedies is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Natural Cold, Cough, and Sore Throat Remedies is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Natural Cold, Cough, and Sore Throat Remedies is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key companies of Natural Cold, Cough, and Sore Throat Remedies include Blackmores Limited, Johnson & Johnson, Zandu Pharmaceuticals, Dabur, Procter and Gamble, Tsumura & Co, Himalaya Global Holdings, Hyland’s and Schwabe Group, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.